Loading...
ROCO
4175
Market cap57mUSD
Jul 09, Last price  
50.80TWD
1D
0.00%
1Q
-8.96%
Jan 2017
-17.38%
IPO
20.75%
Name

MedFirst Healthcare Services lnc

Chart & Performance

D1W1MN
ROCO:4175 chart
P/E
11.86
P/S
0.23
EPS
4.28
Div Yield, %
3.15%
Shrs. gr., 5y
0.63%
Rev. gr., 5y
6.21%
Revenues
8.01b
+3.60%
5,304,985,0005,927,456,0006,540,292,0007,224,083,0007,446,190,0007,734,094,0008,012,666,000
Net income
156m
+122.83%
141,026,000109,847,00067,930,000170,861,00046,803,00069,815,000155,567,000
CFO
904m
+66.71%
0552,820,000999,999,0001,069,680,000795,398,000542,235,000903,967,000
Dividend
Jun 25, 20251.6 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

MedFirst Healthcare Services, Inc., established in 1990 and headquartered in Taoyuan City, Taiwan, is a prominent distributor of medical supplies throughout Taiwan and China. The company's diverse product range includes diabetes management items, respiratory treatment solutions, incontinence and wound care products, various medical devices, ostomy support systems, and pain relief remedies. It also provides nutritional supplements, rehabilitation aids, and products for homecare, childcare, and maternal health. Beyond medical necessities, MedFirst offers general wellness and lifestyle goods, such as beauty products, cosmetics, and health-conscious food and beverages. In addition to its sales through retail outlets and an online platform, the firm serves as a contractor for hospital medical supply departments, acts as an agent for international medical brands, and engages in the trade of water ionizers. Its comprehensive services extend to laundry provisions and prescription drug dispensing. Furthermore, MedFirst is involved in the management of shopping complexes located within hospitals.
IPO date
Dec 21, 2012
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT